Impact of atopic dermatitis on occupational contact dermatitis among young people: A retrospective cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,34 MB, PDF-dokument

  • Jojo B. Dietz
  • Torkil Menné
  • Harald W. Meyer
  • Sven Viskum
  • Mari Ann Flyvholm
  • Ulrik Ahrensbøll-Friis
  • Swen M. John
  • Johansen, Jeanne Duus
Background
Occupational contact dermatitis (OCD) is a common occupational disease. Atopic dermatitis (AD) is a known risk factor for OCD.

Objectives
To determine the prevalence of previously diagnosed AD among young workers with recognized OCD and assess its impact on OCD prognosis.

Methods
A retrospective cohort study. A questionnaire was sent to 6251 workers with recognized OCD who were under 35 years at notification (response rate: 47%). Of the respondents, 2392 answered a question about previous doctor-diagnosed AD and were included in the study. Eczema severity, occupational consequences and quality of life were examined using statistical analyses comparing workers with and without previously diagnosed AD.

Results
The prevalence of previously diagnosed AD was 41.8% (95% CI: 39.8–43.8). Women had a higher AD prevalence, and workers with AD reported OCD at a younger age. Workers with AD reported more frequent and severe eczema symptoms and had a higher risk of OCD negatively affecting job and occupation choices. Health-related quality of life was more adversely affected in workers with AD.

Conclusions
AD significantly impacts severity and has long-term consequences for young people with OCD. Targeted prevention strategies need to be developed.
OriginalsprogEngelsk
BogserieContact Dermatitis
Vol/bind90
Udgave nummer2
Antal sider10
ISSN0105-1873
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
This study is independent research funded by the Danish Working Environment Research Fund (Arbejdsmiljøforskningsfonden; Grant number: 41‐2016‐0920165103816). OpenAI's ChatGPT‐4 was used during the preparation of this work to enhance readability and to perform proofreading. Any editing made with the assistance of ChatGPT‐4 were subsequently reviewed by the authors, who assume full responsibility for the content of the publication.

Publisher Copyright:
© 2023 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.

ID: 369565857